San Francisco, CA – [Insert Date] – Crystalys Therapeutics, a clinical-stage biopharmaceutical company, has successfully closed a...
More than sixty years after Calvin Stevens first synthesized ketamine in the laboratories of Parke-Davis—originally intended as...
By [Your Name/Journalist Name] October 13, 2025 For many, the narrative of breast cancer is one of...
Introduction: The Complexity of Dual Eligibility In the intricate landscape of the American healthcare system, approximately 12...
URBANA-CHAMPAIGN, IL – The most effective way to leverage the transformative power of artificial intelligence in the...
The World Health Organization (WHO) has released its Global status report on blood safety and availability 2025,...
The Dawn of De-escalation: DAPHNe Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Care
The Dawn of De-escalation: DAPHNe Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Care
Introduction: A New Era in Precision Oncology For decades, the prevailing philosophy in oncology was "more is...
In the rapidly evolving landscape of modern medicine, few disciplines have witnessed as dramatic an expansion as...
Washington D.C. – The U.S. Department of Health and Human Services (HHS) has launched "Operation Trialblazer," a...
For decades, the KRAS gene—a master regulator of cellular growth—was considered the "holy grail" of oncology, yet...
